This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Case Reports

. 2005 Jun;20(6):1275-6.

doi: 10.1093/ndt/gfh826. Epub 2005 Apr 12.

Renal toxicity of oxaliplatin

Jacques Labaye, Damien Sarret, Christan Duvic, Michel Hérody, Francis Didelot, Georges Nédélec, Laure-Hélène Noël

PMID: 15827046
DOI: 10.1093/ndt/gfh826

Case Reports

Renal toxicity of oxaliplatin

Jacques Labaye et al. Nephrol Dial Transplant. 2005 Jun.

. 2005 Jun;20(6):1275-6.

doi: 10.1093/ndt/gfh826. Epub 2005 Apr 12.

Authors

Jacques Labaye, Damien Sarret, Christan Duvic, Michel Hérody, Francis Didelot, Georges Nédélec, Laure-Hélène Noël

PMID: 15827046
DOI: 10.1093/ndt/gfh826

No abstract available

PubMed Disclaimer

Similar articles

Oxaliplatin induced acute tubular necrosis.
Jain A, Dubashi B, Parameswaran S, Ganesh RN. Jain A, et al. Indian J Cancer. 2015 Jul-Sep;52(3):363-4. doi: 10.4103/0019-509X.176696. Indian J Cancer. 2015. PMID: 26905139 No abstract available.
Oxaliplatin-induced immune hemolytic anemia: a case report and review of the literature.
Cobo F, De Celis G, Pereira A, Latorre X, Pujadas J, Albiol S. Cobo F, et al. Anticancer Drugs. 2007 Sep;18(8):973-6. doi: 10.1097/CAD.0b013e3280e9496d. Anticancer Drugs. 2007. PMID: 17667605
Secondary acute lymphoblastic leukaemia following oxaliplatin for adjuvant chemotherapy in colon cancer.
Merlin F, Prochilo T, Kildani B, Tucci A, Ferrari S, Rossi G, D'Adda P, Beretta GD. Merlin F, et al. Acta Oncol. 2008;47(3):464-6. doi: 10.1080/02841860701558864. Epub 2007 Sep 12. Acta Oncol. 2008. PMID: 17851873 Review. No abstract available.
Oxaliplatin-induced long QT syndrome in a patient with appendiceal adenocarcinoma.
Woei Chung L, Liao YM, Hsieh CY, Lin CY. Woei Chung L, et al. Acta Oncol. 2009;48(1):156-7. doi: 10.1080/02841860802199816. Acta Oncol. 2009. PMID: 18618340 No abstract available.
[Nephrotoxic effect of antineoplastic drugs].
Robak T, Drzewoski J. Robak T, et al. Przegl Lek. 1983;40(11):807-11. Przegl Lek. 1983. PMID: 6366930 Review. Polish. No abstract available.

See all similar articles

Cited by

Chemotherapy-associated renal dysfunction.
Sahni V, Choudhury D, Ahmed Z. Sahni V, et al. Nat Rev Nephrol. 2009 Aug;5(8):450-62. doi: 10.1038/nrneph.2009.97. Epub 2009 Jun 30. Nat Rev Nephrol. 2009. PMID: 19564889 Review.
A new approach to reduce toxicities and to improve bioavailabilities of platinum-containing anti-cancer nanodrugs.
Liu L, Ye Q, Lu M, Lo YC, Hsu YH, Wei MC, Chen YH, Lo SC, Wang SJ, Bain DJ, Ho C. Liu L, et al. Sci Rep. 2015 Jun 3;5:10881. doi: 10.1038/srep10881. Sci Rep. 2015. PMID: 26039249 Free PMC article.
Acute renal failure related to oxaliplatin-induced intravascular hemolysis.
Ulusakarya A, Misra S, Haydar M, Habert H, Castagne V, Gumus Y, Delmas-Marsalet B, Machover D. Ulusakarya A, et al. Med Oncol. 2010 Dec;27(4):1425-6. doi: 10.1007/s12032-009-9263-3. Epub 2009 Jun 30. Med Oncol. 2010. PMID: 19565364
Preparation and In Vivo Evaluation of Dichloro(1,2-Diaminocyclohexane)platinum(II)-Loaded Core Cross-Linked Polymer Micelles.
Oberoi HS, Nukolova NV, Zhao Y, Cohen SM, Kabanov AV, Bronich TK. Oberoi HS, et al. Chemother Res Pract. 2012;2012:905796. doi: 10.1155/2012/905796. Epub 2012 Jul 15. Chemother Res Pract. 2012. PMID: 22844591 Free PMC article.
Oxaliplatin-induced acute renal failure presenting clinically as thrombotic microangiopathy: think of acute tubular necrosis.
Phan NT, Heng AE, Lautrette A, Kémény JL, Souweine B. Phan NT, et al. NDT Plus. 2009 Jun;2(3):254-6. doi: 10.1093/ndtplus/sfp008. Epub 2009 Feb 4. NDT Plus. 2009. PMID: 25984004 Free PMC article. No abstract available.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Medical
- MedlinePlus Health Information